Ryan Bethencourt

Ryan Bethencourt is CEO of Wild Earth, Inc focused on the future of food for companion animals and a Partner at Babel Ventures investing in Seed and Series A Biotech companies. Ryan is one of the 21st century’s most prolific biotech investors and entrepreneurs through his work funding and building 70+ biotech companies over the last decade.

He previously co-founded and built IndieBio, headed up of life sciences at the XPRIZE Foundation, was formerly the founding CEO of Berkeley Biolabs and spent a decade developing human therapeutics with large companies like Pfizer, Merck, Amgen and Genentech. His work and investments at the interface of science and business have been covered globally.

Ryan has a BSc degree in Biological Sciences (Molecular Genetics) from Warwick University, a joint Masters in Bioscience Enterprise (MBE) from Cambridge University and MIT. He’s also been a Doctor of Philosophy (PhD) Candidate at the Center for Regenerative Medicine at the University of Edinburgh before pivoting to build startups.

SynBioBeta is the leading community of entrepreneurs, investors, policymakers and enthusiasts devoted to the responsible growth of the synthetic biology field. We’re dedicated to telling the stories of the field and companies involved, building their networks, and helping them grow.